used a phage display screening ... with CAR T cell therapy represents a promising avenue for clinical advancement. The PD-1-PD-L1 axis, which impedes CAR-T cell efficiency, could be blocked through ...

Meet the jumbo phage. Scientists believe they’ve cracked the code on how its ‘secret handshakes’ act as a shield against the ...

Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into ...

Their potential as antibacterial agents was appreciated almost immediately, with the first 'phage therapy' trials predating Fleming's discovery of penicillin by approximately a decade. In this ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

Daiichi Sankyo has launched its oncolytic virus therapy Delytact in Japan – its first world market – as a treatment for malignant glioma, an aggressive form of brain cancer. Delytact ...

Structures of Shigella bacteriophage Sf14 show similarity with several features from diverse bacteriophages that, when combined, produce a T = 9 icosahedral capsid coated in decoration ...

The goals of physical therapy and chiropractic care are similar: to help you move better with less pain after an injury or surgery. The reasons for seeing one over the other depend on the nature of ...